Author:
Lv Fengxu,Si Wentao,Xu Xiaodan,He Xiaogang,Wang Ying,Li Yetian,Li Feifei
Reference30 articles.
1. Cancer statistics;Siegel;CA. Cancer J. Clin,2023
2. Pathogenesis of triple-negative breast cancer;Derakhshan;Annu. Rev. Pathol,2022
3. Evolution of breast cancer incidence in young women in a French registry from 1990 to 2018: towards a change in screening strategy?;Hassaine;Breast. Cancer. Res,2022
4. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind;Mittendorf;phase. 3. trial.. Lancet,2020
5. Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC;Ferrari;Int. J. Mol. Sci,2022